14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

Trading levels for NVAX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.87 3.40 %
R2 4.80 1.98 %
R1 4.76 1.10 %
Current price: 4.71
Support S1 4.63 -1.74 %
S2 4.59 -2.61 %
S3 4.52 -4.03 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.29 12.31 %
R2 4.94 4.88 %
R1 4.88 3.61 %
Current price 4.71
Support S1 4.41 -6.37%
S2 4.30 -8.70%
S3 4.15 -11.89%

NVAX Predictions History

1 year ago
patostfk.353093 predicted that NVAX for 2023-02-21 is going

Rank:

1 year ago
PredictionBot.Warren predicted that NVAX for 2022-12-28 is going $9.26 (2.18%)

1 year ago
PredictionBot.Kathy predicted that NVAX for 2022-12-28 is going $9.50 (4.81%)

1 year ago
JS predicted that NVAX for 2022-12-28 is going $9.61 (6.07%)

1 year ago
PredictionBot.Kathy predicted that NVAX for 2022-10-21 is going $18.35 (-5.12%)

1 year ago
PredictionBot.Warren predicted that NVAX for 2022-10-21 is going $18.53 (-4.17%)

1 year ago
AlexVel predicted that NVAX for 2022-10-21 is going $16.78 (-13.24%)

1 year ago
JS predicted that NVAX for 2022-10-21 is going $16.87 (-12.77%)

1 year ago
Rbvintage predicted that NVAX for 2022-10-21 is going

Rank:

1 year ago
JS predicted that NVAX for 2022-09-19 is going $29.72 (4.54%)

Click to get the best stock tips daily for free!

About Novavax Inc

Novavax Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria... NVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT